EHR Machine Learning Predicted Clozapine Initiation in Schizophrenia

EHR Machine Learning Predicted Clozapine Initiation in Schizophrenia

TL;DR: A 2026 preprint in medRxiv trained machine-learning models on Danish electronic health records and found that an XGBoost model predicted clozapine initiation within 365 days with an AUROC of 0.81 in patients with schizophrenia or schizoaffective disorder. Key Findings 229,761 prediction times: The main model used routine psychiatric hospital contacts from 5,806 patients after …

Read more

Cannabis After First Pregnancy Was Not Linked to Hypertension in nuMoM2b Study

Cannabis After First Pregnancy Was Not Linked to Hypertension in nuMoM2b Study

TL;DR: A 2026 study in O&G Open found that cannabis exposure 2–7 years after a first pregnancy was not associated with incident hypertension after adjustment in the nuMoM2b Heart Health Study. Key Findings No adjusted hypertension association: Cannabis exposure was not associated with incident hypertension after adjustment (AOR 1.05; 95% CI, 0.63-1.76). 4,079-person analysis: Researchers …

Read more

Amitriptyline Reduced C6 Glioma Cell Growth but Weakened Radiation Effects With Temozolomide

Amitriptyline Reduced C6 Glioma Cell Growth but Weakened Radiation Effects With Temozolomide

TL;DR: A 2026 in vitro study in Molecular and Clinical Oncology found that amitriptyline reduced C6 glioma cell viability and PD-L1 checkpoint expression, but the same drug weakened the cell-killing effect of radiation when combined with temozolomide. Key Findings Amitriptyline alone reduced glioma cell growth: In non-radiated C6 glioma cultures, 10 micromolar amitriptyline lowered viability …

Read more

South African Adolescent Substance Use Was High in 30-Study Meta-Analysis

South African Adolescent Substance Use Was High in 30-Study Meta-Analysis

TL;DR: A 2026 systematic review and meta-analysis in Drug and Alcohol Review estimated high adolescent substance-use exposure in South Africa, with lifetime alcohol use at 35.09%, tobacco at 25.47%, and cannabis at 10.47% across community and school-based studies. Key Findings 30 publications were included: Researchers synthesized 202 prevalence estimates from South African adolescent samples. Total …

Read more

One Ayahuasca Exposure Reversed Chronic Stress in Zebrafish

One Ayahuasca Exposure Reversed Chronic Stress in Zebrafish

TL;DR: A 2026 study in Psychopharmacology found that after 14 days of unpredictable chronic stress, a single 1-hour ayahuasca exposure restored sociability, reduced anxiety-like behavior, normalized cortisol, and rescued whole-brain BDNF in adult zebrafish within 24 hours. Key Findings 396 fish across 6 groups: Adult zebrafish were split into stressed and non-stressed groups, then exposed …

Read more

CBT-I Self-Help Book Reduced Daily Hypnotic Use in GP Insomnia Patients

CBT-I Self-Help Book Reduced Daily Hypnotic Use in GP Insomnia Patients

TL;DR: A 2025 randomized trial in Scandinavian Journal of Primary Health Care found that a self-help book based on cognitive behavioral therapy for insomnia (CBT-I), a structured non-drug insomnia treatment, reduced daily hypnotic sleep-medication use and anxiety screening rates more than a brief sleep-hygiene handout among Norwegian general-practice patients prescribed zopiclone or zolpidem. Key Findings …

Read more

Ventral Capsule DBS Reduced Severe OCD Symptoms by 60%

Ventral Capsule DBS Reduced Severe OCD Symptoms by 60%

TL;DR: A 2026 medRxiv preprint reported that ventral capsule deep brain stimulation (DBS), an implanted brain-stimulation treatment, reduced severe treatment-resistant obsessive-compulsive disorder (OCD) symptoms by 22 Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) points on average in 10 participants. Key Findings 10 severe OCD patients: Researchers implanted bilateral ventral internal capsule DBS leads in participants with intractable obsessive-compulsive …

Read more

Psilocybin Suppressed SST Interneurons Through 5-HT1A Signaling

Psilocybin Suppressed SST Interneurons Through 5-HT1A Signaling

TL;DR: A 2026 mouse preprint in bioRxiv found that psilocybin reduced firing in somatostatin (SST) interneurons, inhibitory cortical cells that gate dendritic input, while increasing parvalbumin (PV) interneuron firing in the medial frontal cortex. Key Findings SST firing decreased: Opto-tagged SST interneurons fell from 5.5 to 3.7 Hz after psilocybin, while saline did not produce …

Read more

GLP-1 Agonists Showed Dose-Specific ON-Medication Motor Effects in Parkinson’s Disease

GLP-1 Agonists Showed Dose-Specific ON-Medication Motor Effects in Parkinson's Disease

TL;DR: A 2026 systematic review and exploratory network meta-analysis of 5 randomized trials in Neurological Sciences found dose-specific ON-medication motor improvements, measured while usual Parkinson’s drugs were active, for some GLP-1 receptor agonists, glucose-related metabolic hormone drugs, in Parkinson’s disease, but broader motor, non-motor, and quality-of-life evidence remained limited. Key Findings 5 randomized trials: The …

Read more

Antipsychotic D2 Blockade May Disturb Pancreatic Insulin Secretion

Antipsychotic D2 Blockade May Disturb Pancreatic Insulin Secretion

TL;DR: A 2026 systematic review and meta-analysis in Neuropsychopharmacology found that dopamine D2-like receptor activation suppressed glucose-stimulated insulin secretion (GSIS), insulin release after high glucose, in animal pancreatic cells, suggesting one peripheral route by which antipsychotic dopamine blockade can disturb glucose control beyond weight gain. Key Findings 39 eligible studies: Researchers screened 12,457 citations and …

Read more